Division of Urology, University of California, 200 West Arbor Drive 8897, San Diego, CA 92103-8897, USA.
Men with high-risk prostate cancer are at significant risk of progressive, symptomatic disease leading to metastases or death from prostate cancer. Surgery-specifically robotic-assisted laparoscopic prostatectomy (RALP)-is increasingly being considered as a key component of a multimodal strategy to treat these patients. Herein, we review key technical considerations of performing RALP with bilateral pelvic lymphadenectomy in men with high-risk disease. Recent literature supporting the increasing role of surgery either alone or in combination with adjuvant therapies to treat men with high-risk prostate cancer is also reviewed.
Written by:
Stroup SP, Kane CJ. Are you the author?
Reference: ISRN Urol. 2011;2011:201408.
doi: 10.5402/2011/201408
PubMed Abstract
PMID: 22084791
UroToday.com Prostate Cancer Section
